SF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Stifel Financial Corp (SF) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. While the company has shown positive financial performance and growth in client assets, the technical indicators, insider selling trends, and lack of strong trading signals suggest a cautious approach. Additionally, recent legal challenges and a downward trend in analyst price targets further weigh against a buy recommendation.
The MACD histogram is positive and expanding, indicating bullish momentum. However, RSI is neutral at 54.373, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 71.507, with resistance at 73.325 and support at 69.69. Overall, the technical outlook is mixed, leaning slightly bearish.
12% YoY increase in total client assets, reaching $557.71 billion as of February 28,
Strong advisor recruitment and equity market appreciation driving asset growth.
Positive financial performance in Q4 2025, with revenue up 10.15% YoY and EPS up 10.79% YoY.
Significant insider selling, up 4359.55% over the last month.
A $132.5 million arbitration ruling against Stifel, marking a major legal challenge.
Bearish stock trend predictions (-0.68% next day, -3.55% next week, -5.3% next month).
Analysts have lowered price targets, with TD Cowen reducing it from $136 to $92.
In Q4 2025, Stifel Financial reported revenue growth of 10.15% YoY to $1.736 billion, net income growth of 8.67% YoY to $255.041 million, and EPS growth of 10.79% YoY to $1.54. The company demonstrated strong financial performance, but gross margin remained flat.
Analysts are cautious. TD Cowen lowered the price target twice in 2026, from $138 to $136 in January and then to $92 in March, maintaining a Hold rating. Wolfe Research raised the target to $149 in January, citing optimism about retail brokers and alternative managers, but this optimism has not been reflected in recent updates.
